Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.
Where to find us
Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com
Gate2Brain along with other 26 Catalan startups has been awarded with financial support by Startup Capital d’Acció 2020
Press releasesGate2Brain will be attending Bio€quity Europe 2021
EventsGate2Brain, a new member of CataloniaBio & HealthTech
VideosInnovative Training Sessions IDIBGI (Cicle Píndoles d’Innovació IDIBGI)
EventsGate2Brain will be participating at Bio-Europe Spring Digital 2021
EventsDe la Ciència al Mercat (From Science to the Marketplace)
EventsBStartupHealth DemoDay
EventsRound Table in 100tífiques “Public Research and Research at Large Corporation”
EventsGate2Brain co-signs its first article in ACS Publications under the title “Amphiphilic Polymeric Nanoparticles Modified with Protease-Resistant Peptide Shuttle for the Delivery of SN-38 in Diffuse Intrinsic Pontine Glioma”
PublicationsBStartup of Banco de Sabadell invests in Gate2Brain biotech
Press releasesGate2Brain seeks up to 3 million euros to reach the clinical trial
Press releasesThe Mind the Gap program of Botín Foundation invests 1.5 million euros in three new biotech startups
Press releasesLaunch of Gate2Brain, the “key” to transporting drugs into the brain and improving their effectiveness
Press releases